跳至主要内容
临床试验/NCT01579305
NCT01579305已完成不适用

Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement

Allergan Medical2 个研究点 分布在 2 个国家目标入组 285 人开始时间: 2012年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
285
试验地点
2
主要终点
Month 3 Overall Lip Fullness Scale Responder Rate Based on Independent Central Reviewer's Assessment

研究概览

简要总结

The purpose of this study is evaluate lip fullness 3 months following treatment with Juvéderm® Volbella with Lidocaine or Restylane-L®

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Desire enhancement of his/her vermilion borders and/or vermilion mucosa
  • Have a baseline score of Minimal or Mild, as assessed by the Investigator, according to the 5-point LFS (Minimal, Mild, Moderate, Marked, Very Marked)
  • Have established a realistic Lip Fullness treatment goal that the Investigator agrees is achievable

排除标准

  • Have undergone cosmetic facial, lip or perioral procedures [e.g., face-lift, or other surgeries, which may alter the appearance of the lips or perioral area (laser, photomodulation, intense pulsed light, radio frequency, dermabrasion, moderate or greater depth chemical peel, or other ablative procedures), tissue augmentation with dermal fillers or fat injections, or mesotherapy] anywhere in the face or neck, or Botox® Cosmetic injections in the lower face (below the orbital rim), within 6 months prior to entry in the study or be planning to undergo any of these procedures at any time during the study. NOTE: Prior treatment with HA fillers and/or collagen is allowed, provided the treatment was administered more than 6 months prior to study entry
  • Have ever received semi-permanent fillers or permanent facial implants, e.g., calcium hydroxyapatite, L-polylactic acid, polymethylmethacrylate (PMMA), silicone, expanded polytetrafluoroethylene (ePTFE) anywhere in the lips, or be planning to be implanted with any of these products at any time during the study

研究组 & 干预措施

Juvéderm® Volbella with Lidocaine

Experimental

Subjects injected with Juvéderm® Volbella with Lidocaine in their lips

干预措施: Juvéderm® Volbella with Lidocaine (Device)

Restylane-L®

Active Comparator

Subjects injected with Restylane-L® in their lips

干预措施: Restylane-L® (Device)

结局指标

主要结局

Month 3 Overall Lip Fullness Scale Responder Rate Based on Independent Central Reviewer's Assessment

时间窗: 3 months

The primary effectiveness variable is the responder rate (percentage of subjects who show ≥ 1-point improvement on the 5-point Lip Fullness Scale (Minimal, Mild, Moderate, Marked, Very Marked) compared to baseline assessment, as determined by Independent Central Reviewer evaluation of 3D photographic images).

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验